144 related articles for article (PubMed ID: 25093184)
41. SNAI2/Slug gene is silenced in prostate cancer and regulates neuroendocrine differentiation, metastasis-suppressor and pluripotency gene expression.
Esposito S; Russo MV; Airoldi I; Tupone MG; Sorrentino C; Barbarito G; Di Meo S; Di Carlo E
Oncotarget; 2015 Jul; 6(19):17121-34. PubMed ID: 25686823
[TBL] [Abstract][Full Text] [Related]
42. Metastasis-associated protein 3 in colorectal cancer determines tumor recurrence and prognosis.
Huang Y; Li Y; He F; Wang S; Li Y; Ji G; Liu X; Zhao Q; Li J
Oncotarget; 2017 Jun; 8(23):37164-37171. PubMed ID: 28418887
[TBL] [Abstract][Full Text] [Related]
43. Influence of abiraterone acetate on neuroendocrine differentiation in chemotherapy-naive metastatic castration-resistant prostate cancer.
Dong B; Fan L; Wang Y; Chi C; Ma X; Wang R; Cai W; Shao X; Pan J; Zhu Y; Shangguan X; Xin Z; Hu J; Xie S; Kang X; Zhou L; Xue W
Prostate; 2017 May; 77(13):1373-1380. PubMed ID: 28804908
[TBL] [Abstract][Full Text] [Related]
44. Neuroendocrine differentiation as an indicator of chemosensitivity and prognosis in nonsmall cell lung cancer.
Petrović M; Baskić D; Banković D; Ilić N
Biomarkers; 2011 Jun; 16(4):311-20. PubMed ID: 21595568
[TBL] [Abstract][Full Text] [Related]
45. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
[TBL] [Abstract][Full Text] [Related]
46. Expression of neuroendocrine markers in different molecular subtypes of breast carcinoma.
Wachter DL; Hartmann A; Beckmann MW; Fasching PA; Hein A; Bayer CM; Agaimy A
Biomed Res Int; 2014; 2014():408459. PubMed ID: 24701575
[TBL] [Abstract][Full Text] [Related]
47.
Xiao YS; Tong HZ; Yuan XH; Xiong CH; Xu XY; Zeng YF
Exp Biol Med (Maywood); 2020 Aug; 245(14):1233-1241. PubMed ID: 32486849
[TBL] [Abstract][Full Text] [Related]
48. Neuroendocrine differentiation in colorectal carcinomas.
Syversen U; Halvorsen T; Mårvik R; Waldum HL
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):667-74. PubMed ID: 8590163
[TBL] [Abstract][Full Text] [Related]
49. [Relationship of neuroendocrine differentiation to biological behavior of prostate cancer].
Wu XL; Huang KT; Chen W; Chen L; Dong L; Yu ZX
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(7):472-5. PubMed ID: 19567097
[TBL] [Abstract][Full Text] [Related]
50. Stage-stratified analysis of prognostic significance of Bax-interacting factor-1 expression in resected colorectal cancer.
Ko YH; Cho YS; Won HS; An HJ; Sun DS; Hong SU; Park JH; Lee MA
Biomed Res Int; 2013; 2013():329839. PubMed ID: 24175288
[TBL] [Abstract][Full Text] [Related]
51. Characterization of tissue chromogranin A (CgA) immunostaining and clinicohistopathological changes for the 125 Chinese patients with primary small cell carcinoma of the esophagus.
Ku JW; Zhang DY; Song X; Li XM; Zhao XK; Lv S; Hu SJ; Cheng R; Zhou FY; Wu HF; Wang LD
Dis Esophagus; 2017 Aug; 30(8):1-7. PubMed ID: 28575250
[TBL] [Abstract][Full Text] [Related]
52. MicroRNA 211 expression is upregulated and associated with poor prognosis in colorectal cancer: a case-control study.
Sümbül AT; Göğebakan B; Bayram S; Batmacı CY; Öztuzcu S
Tumour Biol; 2015 Dec; 36(12):9703-9. PubMed ID: 26152286
[TBL] [Abstract][Full Text] [Related]
53. Prognostic Threshold of Neuroendocrine Differentiation in Gastric Carcinoma: a Clinicopathological Study of 945 Cases.
Zou Y; Chen L; Wang X; Chen Y; Hu L; Zeng S; Wang P; Li G; Huang M; Wang L; He S; Li S; Jian L; Zhang S
J Gastric Cancer; 2019 Mar; 19(1):121-131. PubMed ID: 30944765
[TBL] [Abstract][Full Text] [Related]
54. Prognostic significance of neuroendocrine differentiation in colorectal adenocarcinoma after radical operation: a meta-analysis.
Zeng YJ; Lai W; Liu L; Wu H; Luo XX; Wang J; Chu ZH
J Gastrointest Surg; 2014 May; 18(5):968-76. PubMed ID: 24549474
[TBL] [Abstract][Full Text] [Related]
55. The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer.
Duncan TJ; Watson NF; Al-Attar AH; Scholefield JH; Durrant LG
World J Surg Oncol; 2007 Mar; 5():31. PubMed ID: 17349047
[TBL] [Abstract][Full Text] [Related]
56. Neuroendocrine differentiation in hormone refractory prostate cancer following androgen deprivation therapy.
Hirano D; Okada Y; Minei S; Takimoto Y; Nemoto N
Eur Urol; 2004 May; 45(5):586-92; discussion 592. PubMed ID: 15082200
[TBL] [Abstract][Full Text] [Related]
57. [Clinicopathologic characteristics of colorectal neuroendocrine tumor].
Jung SH; Kim HC; Yu CS; Chang HM; Ryu MH; Lee JL; Kim JS; Kim JC
Korean J Gastroenterol; 2006 Aug; 48(2):97-103. PubMed ID: 16929153
[TBL] [Abstract][Full Text] [Related]
58. Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma.
Pelosi G; Pasini F; Sonzogni A; Maffini F; Maisonneuve P; Iannucci A; Terzi A; De Manzoni G; Bresaola E; Viale G
Cancer; 2003 May; 97(10):2487-97. PubMed ID: 12733148
[TBL] [Abstract][Full Text] [Related]
59. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
[TBL] [Abstract][Full Text] [Related]
60. Immunohistochemistry-Based Consensus Molecular Subtypes as a Prognostic and Predictive Biomarker for Adjuvant Chemotherapy in Patients with Stage II Colorectal Cancer.
Li Y; Yao Q; Zhang L; Mo S; Cai S; Huang D; Peng J
Oncologist; 2020 Dec; 25(12):e1968-e1979. PubMed ID: 32926498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
